Read the findings & sources
Identity or formulation distinctionAnalytical research identified an acetylated short fragment of thymosin beta-4 in a preparation called TB-500. That work characterized the molecule; it was not a trial demonstrating recovery or healing. Evidence about full-length thymosin beta-4 cannot automatically be assigned to this fragment, and the sequence must match before interpreting any study.

